Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Terns Pharmaceuticals (TERN) Other Non Operating Income (2020 - 2022)

Terns Pharmaceuticals (TERN) has disclosed Other Non Operating Income for 4 consecutive years, with -$5000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Non Operating Income rose 64.29% year-over-year to -$5000.0, compared with a TTM value of -$83000.0 through Sep 2023, down 53.7%, and an annual FY2023 reading of -$314000.0, down 361.76% over the prior year.
  • Other Non Operating Income was -$5000.0 for Q3 2023 at Terns Pharmaceuticals, up from -$60000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $250000.0 in Q2 2020 and bottomed at -$387000.0 in Q3 2020.
  • Average Other Non Operating Income over 4 years is $428.57, with a median of $0.0 recorded in 2021.
  • Peak annual rise in Other Non Operating Income hit 130.77% in 2022, while the deepest fall reached 450.0% in 2022.
  • Year by year, Other Non Operating Income stood at $69000.0 in 2020, then tumbled by 85.51% to $10000.0 in 2021, then crashed by 140.0% to -$4000.0 in 2022, then fell by 25.0% to -$5000.0 in 2023.
  • Business Quant data shows Other Non Operating Income for TERN at -$5000.0 in Q3 2023, -$60000.0 in Q2 2023, and -$4000.0 in Q4 2022.